Hangzhou Tigermed Consulting (300347) - Total Liabilities
Based on the latest financial reports, Hangzhou Tigermed Consulting (300347) has total liabilities worth CN¥4.24 Billion CNY (≈ $619.80 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 300347 net assets growth trend to track the company's year-over-year net asset growth rate.
Hangzhou Tigermed Consulting - Total Liabilities Trend (2009–2025)
This chart illustrates how Hangzhou Tigermed Consulting's total liabilities have evolved over time, based on quarterly financial data. See Hangzhou Tigermed Consulting free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Hangzhou Tigermed Consulting Competitors by Total Liabilities
The table below lists competitors of Hangzhou Tigermed Consulting ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Baiyin Nonferrous Group Co Ltd
SHG:601212
|
China | CN¥44.61 Billion |
|
Pampa Energia SA
BA:PAMP
|
Argentina | AR$3.23 Billion |
|
Shanxi Xishan Coal and Electricity Power Co Ltd
SHE:000983
|
China | CN¥61.21 Billion |
|
OceanaGold Corporation
NYSE:OGC
|
USA | $979.50 Million |
|
Sibanye Stillwater Ltd
JSE:SSW
|
South Africa | ZAC105.57 Billion |
|
Gecina SA
PA:GFC
|
France | €7.44 Billion |
|
Installed Building Products Inc
NYSE:IBP
|
USA | $1.56 Billion |
|
AUTO1 Group SE
F:AG1
|
Germany | €2.31 Billion |
Liability Composition Analysis (2009–2025)
This chart breaks down Hangzhou Tigermed Consulting's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Hangzhou Tigermed Consulting market cap and net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.30 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.20 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.15 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Hangzhou Tigermed Consulting's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Hangzhou Tigermed Consulting (2009–2025)
The table below shows the annual total liabilities of Hangzhou Tigermed Consulting from 2009 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥4.10 Billion ≈ $600.31 Million |
-10.94% |
| 2024-12-31 | CN¥4.61 Billion ≈ $674.08 Million |
-11.87% |
| 2023-12-31 | CN¥5.23 Billion ≈ $764.90 Million |
+9.69% |
| 2022-12-31 | CN¥4.77 Billion ≈ $697.34 Million |
+51.96% |
| 2021-12-31 | CN¥3.14 Billion ≈ $458.89 Million |
+90.34% |
| 2020-12-31 | CN¥1.65 Billion ≈ $241.09 Million |
-19.50% |
| 2019-12-31 | CN¥2.05 Billion ≈ $299.50 Million |
+45.59% |
| 2018-12-31 | CN¥1.41 Billion ≈ $205.72 Million |
+79.81% |
| 2017-12-31 | CN¥781.85 Million ≈ $114.41 Million |
+42.53% |
| 2016-12-31 | CN¥548.54 Million ≈ $80.27 Million |
+0.81% |
| 2015-12-31 | CN¥544.12 Million ≈ $79.62 Million |
+23.46% |
| 2014-12-31 | CN¥440.72 Million ≈ $64.49 Million |
+733.66% |
| 2013-12-31 | CN¥52.87 Million ≈ $7.74 Million |
+37.24% |
| 2012-12-31 | CN¥38.52 Million ≈ $5.64 Million |
-5.43% |
| 2011-12-31 | CN¥40.73 Million ≈ $5.96 Million |
+68.85% |
| 2010-12-31 | CN¥24.12 Million ≈ $3.53 Million |
+4.29% |
| 2009-12-31 | CN¥23.13 Million ≈ $3.38 Million |
-- |
About Hangzhou Tigermed Consulting
Hangzhou Tigermed Consulting Co., Ltd, together with its subsidiaries, provides contract research organization services in the People's Republic of China and internationally. The company offers clinical trial operation services, such as clinical pharmacology, registration and regulatory affairs, scientific affairs, medical translation, pharmacovigilance, real-world research, third-party auditing … Read more